| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 444,621 | 369,490 | 385,846 | 348,150 | | Cost of Revenue | 297,462 | 271,702 | 280,865 | 276,267 | | | Gross Profit | 147,159 | 97,788 | 104,981 | 71,883 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 102,438 | 86,427 | 92,878 | 83,672 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 44,721 | 11,361 | 12,103 | (11,789) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (133) | 1,294 | 42 | (411) | | Earnings Before Interest And Taxes | 44,588 | 12,655 | 12,145 | (12,200) | | Interest Expense | 176 | 188 | 183 | (54) | | Income Before Tax | 44,412 | 12,467 | 11,962 | (12,146) | | Income Tax Expense | 17,781 | 4,900 | 4,817 | (4,625) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,631 | 7,567 | 7,145 | (7,521) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,631 | 7,567 | 7,145 | (7,521) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,631 | $7,567 | $7,145 | ($7,521) |
|
0.51% Nasdaq 
0.49 (1.82%) 
Income Statement
